Specific antioxidant properties of human serum albumin

Abstract

Human serum albumin (HSA) has been used for a long time as a resuscitation fluid in critically ill patients. It is known to exert several important physiological and pharmacological functions. Among them, the antioxidant properties seem to be of paramount importance as they may be implied in the potential beneficial effects that have been observed in the critical care and hepatological settings. The specific antioxidant functions of the protein are closely related to its structure. Indeed, they are due to its multiple ligand-binding capacities and free radical-trapping properties. The HSA molecule can undergo various structural changes modifying its conformation and hence its binding properties and redox state. Such chemical modifications can occur during bioprocesses and storage conditions of the commercial HSA solutions, resulting in heterogeneous solutions for infusion. In this review, we explore the mechanisms that are responsible for the specific antioxidant properties of HSA in its native form, chemically modified forms, and commercial formulations. To conclude, we discuss the implication of this recent literature for future clinical trials using albumin as a drug and for elucidating the effects of HSA infusion in critically ill patients.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 69

1. 1.

   Fanali G di Masi A Trezza V Marino M Fasano M Ascenzi P Human serum albumin: from bench to bedsideMol Aspects Med2012 33209290

   Not in our library10.1016/j.mam.2011.12.002

2. 2.

   Finfer S Bellomo R Boyce N French J Myburgh J Norton R SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unitN Engl J Med2004 35022472256

   Not in our library10.1056/nejmoa040232

3. 3.

   Schortgen F Girou E Deye N Brochard L CRYCO Study GroupThe risk associated with hyperoncotic colloids in patients with shockIntensive Care Med2008 3421572168

   Not in our library10.1007/s00134-008-1225-2

4. 4.

   Dubois MJ Orellana-Jimenez C Melot C De Backer D Berre J Leeman M Brimioulle S Appoloni O Creteur J Vincent JL Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot studyCrit Care Med2006 3425362540

   Not in our library10.1097/01.ccm.0000239119.57544.0c

5. 5.

   Finfer S McEvoy S Bellomo R McArthur C Myburgh J Norton R SAFE Study InvestigatorsImpact of albumin compared to saline on organ function and mortality of patients with severe sepsisIntensive Care Med2011 378696

   Not in our library10.1007/s00134-010-2039-6

6. 6.

   Sort P Navasa M Arroyo V Aldeguer X Planas R Ruiz-del-Arbol L Castells L Vargas V Soriano G Guevara M Gines P Rodes J Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitisN Engl J Med1999 341403409

   Not in our library10.1056/nejm199908053410603

7. 7.

   Tollefson BJ Jones AE Does resuscitation with albumin-containing solutions improve mortality in sepsis?Ann Emerg Med2012 59432433

   Not in our library10.1016/j.annemergmed.2011.11.014

8. 8.

   Delaney AP Dan A McCaffrey J Finfer S The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysisCrit Care Med2011 39386391

   Not in our library10.1097/ccm.0b013e3181ffe217

9. 9.

   Vincent JL Navickis RJ Wilkes MM Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trialsCrit Care Med2004 3220292038

   Not in our library10.1097/01.ccm.0000142574.00425.e9

10. 10.

    Perel P Roberts I Colloids versus crystalloids for fluid resuscitation in critically ill patientsCochrane Database Syst Rev2012 6CD000567

    Not in our library10.1002/14651858.cd000567.pub5

11. 11.

    Quinlan GJ Margarson MP Mumby S Evans TW Gutteridge JM Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletionClin Sci (Lond)1998 95459465

    Not in our library10.1042/cs19980191

12. 12.

    Quinlan GJ Mumby S Martin GS Bernard GR Gutteridge JM Evans TW Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injuryCrit Care Med2004 32755759

    Not in our library10.1097/01.ccm.0000114574.18641.5d

13. 13.

    Jain RK Chakravorty N Chakravorty D Bhattacharya PK Yadava A Agarwal RC Albumin: an overview of its place in current clinical practiceIndian J Anaesth2004 48433438

    Not in our library

14. 14.

    Rostoker G Griuncelli M Loridon C Bourlet T Illouz E Benmaadi A Modulation of oxidative stress and microinflammatory status by colloids in refractory dialytic hypotensionBMC Nephrol2011 1258

    Not in our library10.1186/1471-2369-12-58

15. 15.

    Roche M Rondeau P Singh NR Tarnus E Bourdon E The antioxidant properties of serum albuminFEBS Lett2008 58217831787

    Not in our library10.1016/j.febslet.2008.04.057

16. 16.

    Oettl K Stauber RE Physiological and pathological changes in the redox state of human serum albumin critically influence its binding propertiesBr J Pharmacol2007 151580590

    Not in our library10.1038/sj.bjp.0707251

17. 17.

    Andrades ME Ritter C Dal-Pizzol F The role of free radicals in sepsis developmentFront Biosci2009 1277287

    Not in our library10.2741/e27

18. 18.

    Huet O Dupic L Harrois A Duranteau J Oxidative stress and endothelial dysfunction during sepsisFront Biosci2011 1619861995

    Not in our library10.2741/3835

19. 19.

    Ait-Oufella H Maury E Lehoux S Guidet B Offenstadt G The endothelium: physiological functions and role in microcirculatory failure during severe sepsisIntensive Care Med2010 3612861298

    Not in our library10.1007/s00134-010-1893-6

20. 20.

    Huet O Obata R Aubron C Spraul-Davit A Charpentier J Laplace C Nguyen-Khoa T Conti M Vicaut E Mira JP Duranteau J Plasma-induced endothelial oxidative stress is related to the severity of septic shockCrit Care Med2007 35821826

    Not in our library10.1097/01.ccm.0000257464.79067.af

21. 21.

    Galley HF Oxidative stress and mitochondrial dysfunction in sepsisBr J Anaesth2011 1075764

    Not in our library10.1093/bja/aer093

22. 22.

    Parola M Robino G Oxidative stress-related molecules and liver fibrosisJ Hepatol2001 35297306

    Not in our library10.1016/s0168-8278(01)00142-8

23. 23.

    Izzet T Osman K Ethem U Nihat Y Ramazan K Mustafa D Hafize U Riza KA Birsen A Habibe G Seval A Gonul S Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metalsWorld J Gastroenterol2005 1135703573

    Not in our library10.3748/wjg.v11.i23.3570

24. 24.

    Lieber CS Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseasesAdv Pharmacol1997 38601628

    Not in our library10.1016/s1054-3589(08)61001-7

25. 25.

    Peters T Jr Serum albuminAdv Protein Chem1985 37161245

    Not in our library10.1016/s0065-3233(08)60065-0

26. 26.

    Carter DC Ho JX Structure of serum albuminAdv Protein Chem1994 45153203

    Not in our library10.1016/s0065-3233(08)60640-3

27. 27.

    Peters TJ All about albumin1996 San Diego: Academic

    Not in our library

28. 28.

    Otagiri M Chuang VT Pharmaceutically important pre- and posttranslational modifications on human serum albuminBiol Pharm Bull2009 32527534

    Not in our library10.1248/bpb.32.527

29. 29.

    Guidet B Richard C, Teboul JL, Vincent JLAlbumin. Acute circulatory failureRéanimation2009 Elsevier343356

    Not in our library

30. 30.

    Stohs SJ Bagchi D Oxidative mechanisms in the toxicity of metal ionsFree Radic Biol Med1995 18321336

    Not in our library10.1016/0891-5849(94)00159-h

31. 31.

    Halliwell B Albumin–an important extracellular antioxidant?Biochem Pharmacol1988 37569571

    Not in our library10.1016/0006-2952(88)90126-8

32. 32.

    Young IS Woodside JV Antioxidants in health and diseaseJ Clin Pathol2001 54176186

    Not in our library10.1136/jcp.54.3.176

33. 33.

    Jacobsen C Lysine residue 240 or human serum albumin is involved in high-affinity binding of bilirubinBiochem J1978 171453459

    Not in our library10.1042/bj1710453

34. 34.

    Neuzil J Stocker R Free and albumin-bound bilirubin are efficient co-antioxidants for a-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidationJ Biol Chem1994 2691671216719

    Not in our library

35. 35.

    Papatheodorou L Weiss N Vascular oxidant stress and inflammation in hyperhomocysteinemiaAntioxid Redox Signal2007 919411958

    Not in our library10.1089/ars.2007.1750

36. 36.

    Rubbo H Parthasarathy S Barnes S Kirk M Kalyanar-aman B Freeman BA Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivativesArch Biochem Biophys1995 3241525

    Not in our library10.1006/abbi.1995.9935

37. 37.

    Quinlan GJ Martin GS Evans TW Albumin: biochemical properties and therapeutic potentialHepatology2005 4112111219

    Not in our library10.1002/hep.20720

38. 38.

    Colombo G Clerici M Giustarini D Rossi R Milzani A Dalle-Donne I Redox albuminomics: oxidized albumin in human diseasesAntioxid Redox Signal2012 1715151527

    Not in our library10.1089/ars.2012.4702

39. 39.

    King TP On the sulfhydryl group of human plasma albuminJ Biol Chem1961 236PC5

    Not in our library

40. 40.

    Gutteridge JM Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritisBiochim Biophys Acta1986 869119127

    Not in our library10.1016/0167-4838(86)90286-4

41. 41.

    Turell L Botti H Carballal S Ferrer-Sueta G Souza JM Durán R Freeman BA Radi R Alvarez B Reactivity of sulfenic acid in human serum albuminBiochemistry2008 47358367

    Not in our library10.1021/bi701520y

42. 42.

    Carballal S Radi R Kirk MC Barnes S Freeman BA Alvarez B Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitriteBiochemistry2003 4299069914

    Not in our library10.1021/bi027434m

43. 43.

    Turell L Carballal S Botti H Radi R Alvarez B Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartmentBraz J Med Biol Res2009 42305311

    Not in our library10.1590/s0100-879x2009000400001

44. 44.

    Cantin AM Paquette B Richter M Larivée P Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activationAm J Respir Crit Care Med2000 16215391546

    Not in our library10.1164/ajrccm.162.4.9910106

45. 45.

    Rafikova O Rafikov R Nudler E Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular controlProc Natl Acad Sci USA2002 9959135918

    Not in our library10.1073/pnas.092048999

46. 46.

    Bourdon E Loreau N Lagrost L Blache D Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albuminFree Radic Res2005 391520

    Not in our library10.1080/10715760400024935

47. 47.

    Bourdon E Blache D The importance of proteins in defense against oxidationAntioxid Redox Signal2001 3293311

    Not in our library10.1089/152308601300185241

48. 48.

    Berlett BS Stadtman ER Protein oxidation in aging, disease, and oxidative stressJ Biol Chem1997 2722031320316

    Not in our library10.1074/jbc.272.33.20313

49. 49.

    Holt ME Ryall ME Campbell AK Albumin inhibits human polymorphonuclear leucocyte luminol-dependent chemiluminescence: evidence for oxygen radical scavengingBr J Exp Pathol1984 65231241

    Not in our library

50. 50.

    Kawakami A Kubota K Yamada N Tagami U Takehana K Sonaka I Suzuki E Hirayama K Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functionsFEBS J2006 27333463357

    Not in our library10.1111/j.1742-4658.2006.05341.x

51. 51.

    Alahmad Y Tran NT Le Potier I Forest E Jorieux S Taverna M A new CZE method for profiling human serum albumin and its related forms to assess the quality of biopharmaceuticalsElectrophoresis2011 32292299

    Not in our library10.1002/elps.201000399

52. 52.

    Bar-Or D Bar-Or R Rael LT Gardner DK Slone DS Craun ML Heterogeneity and oxidation status of commercial human albumin preparations in clinical useCrit Care Med2005 3316381641

    Not in our library10.1097/01.ccm.0000169876.14858.91

53. 53.

    Iwao Y Anraku M Yamasaki K Kragh-Hansen U Kawai K Maruyama T Otagiri M Oxidation of Arg-410 promotes the elimination of human serum albuminBiochim Biophys Acta2006 1764743749

    Not in our library10.1016/j.bbapap.2006.01.011

54. 54.

    Rondeau P Bourdon E The glycation of albumin: structural and functional impactsBiochimie2011 93645658

    Not in our library10.1016/j.biochi.2010.12.003

55. 55.

    Iberg N Fluckiger R Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sitesJ Biol Chem1986 2611354213545

    Not in our library

56. 56.

    Ahmed N Dobler D Dean M Thornalley PJ Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activityJ Biol Chem2005 28057245732

    Not in our library10.1074/jbc.m410973200

57. 57.

    Shaklai N Garlick RL Bunn HF Nonenzymatic glycosylation of human serum albumin alters its conformation and functionJ Biol Chem1984 25938123817

    Not in our library

58. 58.

    Rondeau P Singh N Caillens H Bourdon E Oxidative stresses induced by glycated human or bovine serum albumins on human monocytesFree Radic Biol Med2008 45799812

    Not in our library10.1016/j.freeradbiomed.2008.06.004

59. 59.

    Sakata N Moh A Takebayashi S Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albuminHeart Vessels2002 172229

    Not in our library10.1007/s003800200038

60. 60.

    Bar-Or D Rael LT Bar-Or R Slone DS Craun ML The formation and rapid clearance of a truncated albumin species in a critically ill patientClin Chim Acta2006 365346349

    Not in our library10.1016/j.cca.2005.08.011

61. 61.

    Evans TW Review article: albumin as a drug–biological effects of albumin unrelated to oncotic pressureAliment Pharmacol Ther2002 16Suppl 5611

    Not in our library10.1046/j.1365-2036.16.s5.2.x

62. 62.

    Flan B Quality control of human albumin solutionsAnn Fr Anesth Reanim1996 15547552

    Not in our library10.1016/0750-7658(96)83218-7

63. 63.

    Otagiri M Kragh-Hansen U Imai T Albumins with new functions and clinical applicationsDrug Metab Pharmacokinet2009 24285286

    Not in our library10.2133/dmpk.24.285

64. 64.

    Bar-Or D Thomas GW Bar-Or R Rael LT Scarborough K Rao N Shimonkevitz R Commercial human albumin preparations for clinical use are immunosuppressive in vitroCrit Care Med2006 3417071712

    Not in our library10.1097/01.ccm.0000217923.53680.4c

65. 65.

    Anraku M Kouno Y Kai T Tsurusaki Y Yamasaki K Otagiri M The role of N-acetyl-methioninate as a new stabilizer for albumin productsInt J Pharm2007 3291924

    Not in our library10.1016/j.ijpharm.2006.08.014

66. 66.

    Ogasawara Y Namai T Togawa T Ishii K Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible biomarker for oxidative stressBiochem Biophys Res Commun2006 340353358

    Not in our library10.1016/j.bbrc.2005.11.183

67. 67.

    Qian J Tang Q Cronin B Markovich R Rustum A Development of a high performance size exclusion chromatography method to determine the stability of Human Serum Albumin in a lyophilized formulation of Interferon alfa-2bJ Chromatogr A2008 11944856

    Not in our library10.1016/j.chroma.2008.01.040

68. 68.

    Kremer H Baron-Menguy C Tesse A Gallois Y Mercat A Henrion D Andriantsitohaina R Asfar P Meziani F Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent propertiesCrit Care Med2011 3914141422

    Not in our library10.1097/ccm.0b013e318211ff6e

69. 69.

    Gattinoni L Albumin in Severe Sepsis and Septic Shock: the ALBIOS Study2012 Lisbon: ESICM Lives 2012 Lisbon, 25th annual congress20113-17 October 2012. Session fluid therapy in septic shock

    Not in our library

Cited by papers we hold 8

• Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice · 2023
  No notice
• Risk Factors and Clinical Characteristics of Neonatal Acute Respiratory Distress Syndrome Caused by Early Onset Sepsis · 2022
  Not checked
• Serum Albumin: A Multifaced Enzyme · 2021
  No notice
• Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties · 2021
  No notice
• Structural and Biochemical Features of Human Serum Albumin Essential for Eukaryotic Cell Culture · 2021
  No notice
• Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review · 2020
  No notice
• AMBAR, an Encouraging Alzheimer's Trial That Raises Questions · 2020
  Not checked
• Albumin administration in the acutely ill: what is new and where next? · 2014
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.